The Best in Breast Cancer Diagnosis
Oct 01, 2018
Now the most common form of cancer in the UK, one in every eight women will be diagnosed with breast cancer during their lifetime1.
The National Breast Cancer Screening Programme, established in 1987, continues to strive to provide the best in breast cancer care. However, the percentage of women attending screening has fallen to its lowest rate in ten years, at 4% lower than European targets, despite the fact that 7 in every 100 women will be called back after their initial screening2,3.
Every year in the UK, the programme detects cancer in approximately 8 of every 1000 women screened but this is achievable only through widespread attendance of routine screening4. To continue to provide the best in breast cancer care, it is important to recognise key advances in technology - enabling healthcare professionals to actively prevent, detect and treat breast cancer.
Siemens Healthineers have been pioneers in breast imaging since the late 1950s and continue to contest the limits of this field, not only technically, but with an archetypal patient focused approach. Addressing the 45% of women stating discomfort as a reason for non-attendance, recent developments in our mammography systems target the current challenges of the national screening programme5. With features such as SoftCompTM, OpCompTM, MoodLightTM and PRIMETM dose reducing technology, they allow for easier positioning and greater comfort. These features aim to optimise patient experience and offer advanced screening techniques, personalised exposure and safety piece of mind.
Find out more about our mammography solutions, including the new Mammomat RevelationTM here.
1According to Breast Cancer Care: www.breastcancercare.org.uk
2Data from NHS Digital report: Breast Screening Programme England, 2016-17. Available from www.digital.nhs.uk
3According to Cancer Research UK: www.cancerresearchuk.org
4According to Cancer Research UK: www.cancerresearchuk.org
5The effect of mammography pain on repeat participation in breast cancer screening: ‘A systematic review’ by Patsy Whelehan, Andy Evans, Mary Wells and Steve MacGillivray